Modern Trials
Modern Trials is a healthcare technology company dedicated to improving clinical trial access and efficiency. They partner with healthcare organizations, leverage electronic health data, and provide AI-driven tools to identify suitable patients for clinical trials, reduce time-to-market for therapeutics, and enhance patient care. Their mission is to provide the opportunity for a longer and better life to every patient in need, through innovative solutions, regulatory expertise, and strategic collaborations.
Industries
Nr. of Employees
small (1-50)
Modern Trials
Miami, Florida, United States, North America
Products
AI-driven trial recruitment platform
A HIPAA-compliant, integrated software platform for clinical trial recruitment that automates protocol data extraction, candidate upload, outreach (text/voice), decision-tree screening, scheduling, eSignature, secure document storage, and administrative analytics.
AI-driven trial recruitment platform
A HIPAA-compliant, integrated software platform for clinical trial recruitment that automates protocol data extraction, candidate upload, outreach (text/voice), decision-tree screening, scheduling, eSignature, secure document storage, and administrative analytics.
Services
Provide healthcare organizations with tools and services to use their own EHR data for prescreening, conduct feasibility analyses, increase enrollment, offer prescreened patient outreach, and generate revenue share with no operational overhead for the site.
Recruitment services that deliver prescreened and double-screened candidate referrals to life science organizations and CROs, with the objective of reducing time-to-market and recruitment variable costs.
Consulting services including trial design, feasibility assessments, and research regulatory support to improve competitiveness for sponsored research and federal funding.
Outsourced enrollment services to conduct candidate outreach, live screening, source document collection and ongoing patient support during trial participation (availability stated as 2025).
Provide healthcare organizations with tools and services to use their own EHR data for prescreening, conduct feasibility analyses, increase enrollment, offer prescreened patient outreach, and generate revenue share with no operational overhead for the site.
Recruitment services that deliver prescreened and double-screened candidate referrals to life science organizations and CROs, with the objective of reducing time-to-market and recruitment variable costs.
Consulting services including trial design, feasibility assessments, and research regulatory support to improve competitiveness for sponsored research and federal funding.
Outsourced enrollment services to conduct candidate outreach, live screening, source document collection and ongoing patient support during trial participation (availability stated as 2025).
Expertise Areas
- Clinical trial patient identification and recruitment
- Regulatory compliance and clinical trial regulatory consulting
- EHR integration and health data interoperability
- Digital health platform development and workflow automation
Key Technologies
- EHR/EMR integration
- FHIR
- HL7
- OMOP Common Data Model
News & Updates
Modern Trials joins ARPA-H to transform clinical trial access.
Modern Trials is featured for democratizing access to advanced therapeutics.
Modern Trials collaborates with InterSystems to improve patient access to clinical trials.
Blackford Middleton, a renowned healthcare IT leader, joins Modern Trials.
Modern Trials CEO receives FACHE healthcare leadership certification.
Modern Trials is highlighted for its innovative approach in clinical trials.
Modern Trials joins ARPA-H to transform clinical trial access.
Modern Trials is featured for democratizing access to advanced therapeutics.
Modern Trials collaborates with InterSystems to improve patient access to clinical trials.
Blackford Middleton, a renowned healthcare IT leader, joins Modern Trials.
Modern Trials CEO receives FACHE healthcare leadership certification.
Modern Trials is highlighted for its innovative approach in clinical trials.